Eisbach Bio is an innovative start-up in biotechnology founded in 2019 as a spin-out of the Biomedical Center Munich. We are developing novel drugs that successfully target molecular vulnerabilities arising in cancer genomes. Eisbach will beat cancer at its own game." title="" class="btn" data-container="body" data-html="true" data-id="235469" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Eisbach Bio GmbH"> 3,364
Activities
Technologies
Entity types
Location
Innovations- und Gründerzentrum Biotechnologie (IZB), Am Klopferspitz 19, 82152 Planegg, Germany
Planegg
Germany
Employees
Scale: 11-50
Estimated: 12
Engaged corporates
2Added in Motherbase
1 year agoTargeting synthetic lethality in cancer
Eisbach Bio is an innovative start-up in biotechnology founded in 2019 as a spin-out of the Biomedical Center Munich. We are developing novel drugs that successfully target molecular vulnerabilities arising in cancer genomes.
Eisbach will beat cancer at its own game.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Other 30 Sep 2023 | | |
![]() Fresenius Medical Care Pharmaceutical, Hospitals and Health Care | Fresenius Medical Care Pharmaceutical, Hospitals and Health Care | Other 30 Sep 2023 | |